The X chromosome and ovarian failure.
Davison
R M
RM
Cobbold Laboratories, Division of Endocrinology, Department of Medicine, University College London School of Medicine, London, UK. rina.davison@ucl.ac.uk
Davis
C J
CJ
Conway
G S
GS
D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics; D004303:Dosage Compensation, Genetic; D005260:Female; D000080865:Formins; D005600:Fragile X Syndrome / Q000235:genetics; D017353:Gene Deletion; D006609:High Mobility Group Proteins / Q000235:genetics; D006801:Humans; D008297:Male; D010053:Ovary / Q000002:abnormalities*; D016649:Primary Ovarian Insufficiency / Q000235:genetics*; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin / Q000235:genetics; D011962:Receptors, FSH / Q000235:genetics; D055748:SOXB1 Transcription Factors; D014157:Transcription Factors; D014960:X Chromosome; D016335:Zinc Fingers / Q000235:genetics
D048868:Adaptor Proteins, Signal Transducing; D002352:Carrier Proteins; C108962:DIAPH1 protein, human; D004268:DNA-Binding Proteins; D000080865:Formins; D006609:High Mobility Group Proteins; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin; D011962:Receptors, FSH; C527785:SOX3 protein, human; D055748:SOXB1 Transcription Factors; D014157:Transcription Factors